LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.

Yan SP, Chu DX, Qiu HF, Xie Y, Wang CF, Zhang JY, Li WC, Guo RX.

Open source

DOI
10.1111/jcmm.14161
Published
2019-01-29
Container
J Cell Mol Med
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jcmm.14161,
  title = {LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.},
  author = {Yan SP and  Chu DX and  Qiu HF and  Xie Y and  Wang CF and  Zhang JY and  Li WC and  Guo RX.},
  year = {2019},
  journal = {J Cell Mol Med},
  doi = {10.1111/jcmm.14161},
  url = {https://doi.org/10.1111/jcmm.14161}
}

RIS

TY  - JOUR
TI  - LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
AU  - Yan SP
AU  -  Chu DX
AU  -  Qiu HF
AU  -  Xie Y
AU  -  Wang CF
AU  -  Zhang JY
AU  -  Li WC
AU  -  Guo RX.
PY  - 2019
JO  - J Cell Mol Med
DO  - 10.1111/jcmm.14161
UR  - https://doi.org/10.1111/jcmm.14161
ER  - 

APA

SP, Y., DX, C., HF, Q., Y, X., CF, W., JY, Z., WC, L., & RX., G. (2019). LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.. J Cell Mol Med. https://doi.org/10.1111/jcmm.14161

Source records